By Kevin E. Noonan –

A little more than a year after dramatically changing the infrastructure of how petitions to the Patent Trial and Appeal Board were assessed and approved (see “Revision to Rules of Practice Before the Patent Trial and Appeal Board“), or not (see “New Director Overturns PTAB Procedural Precedents: Part I“; “USPTO Proposed New Rules Limiting the Availability of Inter Partes Review, But Are They Legal?“; “Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution“), U.S. Patent and Trademark Office Director John A. Squires, joined by USPTO Solicitor John F. Duffy promulgated a Memorandum (see below) essentially changing the agency’s program 180 degrees. That Memorandum, entitled “Returning Merits-Based Considerations to the PTAB,” was issued on November 10, 2026 and addressed to the Judges of the Patent Trial and Appeal Board.
The Memorandum is not a complete retreat from last year’s model, however, the Director mentioning the return of only certain merits-based considerations to the PTAB judges. Instead, the Director informs the judges that they will have institution decision-making power over those IPR and PGR petitions that pass muster with the Director in the first instance, subject to further review by the patent judging corps.
The Director reiterated his “stated goals” in entering the directive last year, to be:
• To realign the duties and responsibilities of the Director;
• To remove a perceived referral-signal bias through centralization;
• To enhance transparency and public trust; and
• To eliminate the unfounded perception of self-interest.
The Memorandum also notes that the “Interim Processes for PTAB Workload Management” earlier implemented by the Office bifurcated decisions on discretionary grounds and on merits-based considerations. These efforts permitted the Director to set policies as illustrated under Magnolia Medical Technologies, Inc. v. Kurin, Inc., IPR2026-00097, Paper 17 (Director May 14, 2026) (precedential). Not surprisingly the Director reports that “data collected over the past eighteen months clearly demonstrates that parties have adapted to be more in-line with the [America Invents Act] and are following the Magnolia framework,” changing from 60% of petitions being discretionally denied in June 2025 to 15% in September 2026.
With regard to centralized authority, the Director announced that he had made 325 decisions in concert with PTAB judges, whose efforts and acumen garnered his praise. Coming in for specific praise was the “Learning from Outcomes to Optimize Patents” or LOOP protocol, to effectuate transfer of lessoned learned from PTAB proceedings into the examining corps (amounting to over 4200 hours of live training) and the STRONG program (from “Support, Training, Resources, Opportunities, Networking, and Guidance”) (the latter program engendering encomiums for Solicitor John Duffy).
One important change is that “once the PTAB has instituted review in a case, a new panel of judges will be assigned to conduct the trial” to “ensure that the USPTO’s administration of lPRs and PGRs remains aligned with the spirit and intent of 35 U.S.C. §§ 314(a) and 324(a).”
After appropriate hagiography about the Office and the PTAB, the Memorandum turns to the substance of what is termed the “return of merits-based considerations,” effective Monday, November 16, 2026. The Director makes a strict dichotomy: he shall be responsible for making institution decisions that do not involve the merits of petition challenges, but once his decisions are made it will be up to the PTAB judges to take up substantive challenges under the statute. As explained in a footnote, the PTAB judges will also be tasked with making non-discretionary judgments on instances such as failure to satisfy a statutory requirement (failure to demonstrate that at least one claim is more likely than not to be patentable, for example). The Memorandum also sets forth that it supersedes the prior “Director Institution of AIA Trial Proceedings.”
The Memorandum then sets forth the express guidelines that the PTAB should follow in making institution decisions. These include:
• For prior art-based grounds, the petition has the burden to point out how the prior art anticipates or renders obvious “each limitation of each challenged claim” element-by-element with specificity under 37 C.F.R. §§ 42.104(6)(4) and 42.204(b)(4);
• Should the petitioner fail to satisfy these requirements, the PTAB should deny the petition;
• If a patent owner’s preliminary response raises a “reasonable argument, well-supported with reliable, credible evidence,” then the PTAB should deny the petition;
• If the PTAB recognizes that there is a “reasonable argument, well-supported with reliable, credible evidence,” that shows the petitioner has not met the institution standard then the PTAB should deny the petition; and
• If the arguments on each side are equivalent (“in equipoise”), then the PTAB should deny the petition on the grounds that the petitioner has not met the “reasonable likelihood of IPR” standard.
The Memorandum further asserts that these guidelines are “illustrative and not exhaustive,” and are tied to the statutory framework and relevant to precedent including SAS Institute v. Iancu, 584 U.S. 357 (2018), and Amazon.com, Inc. v. Barnesandnoble.com, Inc., 239 E3d 1343, 1350 (Fed. Cir. 2001), abrogated on other grounds by Socket Sols., LLC v. Import Global, LLC, No. 2025-1121, 2026 WL 2234259 (Fed. Cir. Aug. 4, 2026). The Director provides portions of the legislative history to illustrate the intended “elevated thresholds” for institution (as opposed to in ex parte reexams, a “substantial new question of patentability”); a “reasonable likelihood” test for preliminary injunctions; and the “more likely than not” standard for post-grant review. In the latter instance the guidelines assert that “[t]he Office wants to ensure that petitioners raising such issues present a complete case at the outset and are not relying on obtaining information in discovery in the post-grant review in order to satisfy their ultimate burden of showing invalidity by a preponderance of the evidence.” And the Director sets our exemplary Federal Circuit decisions on how injunction standards are to be implemented. These examples are intended to provide instances where a petitioner does not meet their substantive institution burden.
The Director reminds the PTAB judges corps that if he were to determine institution standards are not met, he will provide a written opinion denying institution or a summary notice, or if such standards are met assign the petition to a three-judge panel. The Director justifies summary dispositions under Oil States Energy Servs., LLC v. Greene’s Energy Grp., LLC, 584 U.S. 325, 335 (2018). The Memorandum then sets forth what will be expected from a three-judge panel regarding the grounds for granting the institution petition, providing Director decisions to guide the PTAB judges such as Merck Sharp & Dahme LLC v. Pogona, LLC, IPR2026-00374, Paper 18 (Director Oct. 26, 2026), and Samsung Elecs. Co. v. Whirlpool Corp., IPR2026~00336, Paper 16 (Director Oct. 23, 2026). Once the institution petition is granted, the proceedings will be given to a different panel that does not include any of the judges assigned to the institution panel.
For the absence of doubt, the Memorandum ends with the admonition that “[f]inally, this delegation of authority to the PTAB does not divest from the Director the power to make institutions under the original statutory framework, which vests the Director with the power to grant or deny institution.”
The consequences of giving exclusive control over IPR proceedings to the Director under the original policy have been dramatic, with the number of IPR proceedings plummeting (see “The PTAB Pendulum Swings: How IPR Denials are Reshaping Patent Owner and Challenger Strategies“) and petitioners turning to alternative ways to challenged granted patents, specifically ex parte reexamination, despite the limitations of these procedures. Inter partes reviews in particular have been used to challenge and invalidate a high percentage of granted patents, and the Director’s Memorandum of a year ago has changed the landscape in that regard. It can be expected that the pendulum will once again swing back towards successful challenges, but the extent to which that happens will take time to tell.

Leave a Reply